ZYMOBYL Trademark

Trademark Overview


On Monday, September 23, 2019, a trademark application was filed for ZYMOBYL with the United States Patent and Trademark Office. The USPTO has given the ZYMOBYL trademark a serial number of 88627239. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 11, 2021. This trademark is owned by Aeglea BioTherapeutics, Inc.. The ZYMOBYL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of Arginase 1 deficiency; biopharmaceutical preparations for the treatment of rare genetic diseases; biopharmaceutical preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations for the treatment of rare genetic diseases; biotherapeutic preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of rare genetic diseases; biotherapeutic preparations and substances for the treatment of Arginase 1 deficiency; enzyme replacement therapy preparations for medical purposes
zymobyl

General Information


Serial Number88627239
Word MarkZYMOBYL
Filing DateMonday, September 23, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of Arginase 1 deficiency; biopharmaceutical preparations for the treatment of rare genetic diseases; biopharmaceutical preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations for the treatment of rare genetic diseases; biotherapeutic preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of rare genetic diseases; biotherapeutic preparations and substances for the treatment of Arginase 1 deficiency; enzyme replacement therapy preparations for medical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAeglea BioTherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAustin, TX 78746

Party NameAeglea BioTherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78746

Trademark Events


Event DateEvent Description
Monday, January 11, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 11, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 9, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 2, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 23, 2019NON-FINAL ACTION E-MAILED
Monday, December 23, 2019NON-FINAL ACTION WRITTEN
Monday, December 23, 2019ASSIGNED TO EXAMINER
Friday, September 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 26, 2019NEW APPLICATION ENTERED IN TRAM